(RTTNews) - Immatics N.V. (IMTX) Thursday reported updated data from the Phase 1b study of its ACTengine cell therapy IMA203 in melanoma patients. ACTengine is a personalized therapy in which a ...
Texas Tech will wear special uniforms featuring former quarterback Patrick Mahomes' "Gladiator" brand logo as part of their ...
Company announces updated Phase 1b clinical data on ACTengine® IMA203 targeting PRAME in 28 heavily pretreated metastatic melanoma patients with substantially enhanced maturity compared to the last ...